Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Daniel Riskin, 33
UCLA Medical Center
Developing devices for wound closure and early heart-attack intervention

In addition to working about 80 hours a week as a surgical resident at the University of California, Los Angeles, Medical Center, Daniel Riskin is building companies to develop and market new medical devices. “Physicians have an obligation to innovate,” says Riskin.

While training to be a doctor at Boston University and Tufts University, Riskin dabbled in technology development, writing software to help physicians manage their practices and researching different designs for surgical clips with a medical-device company. But he wanted to do more – to come up with his own inventions and bring them into widespread use. Thus he enrolled, partway through his residency, at MIT’s Sloan School of Management. While studying for his MBA, he kept up his operating-room skills by working at private surgical practices on evenings and weekends.

After graduating from Sloan, Riskin was named the first fellow in Stanford University’s new surgical-innovation program. At Stanford, he and his collaborators developed an elastic, adhesive, polymer-based patch that they hope will provide a less painful alternative to staples or stitches as a way to close up wounds and surgical incisions. He is now forming a company to commercialize the patch, which he expects will also reduce scarring.

Riskin also helps doctors with few business skills or little experience to become innovators themselves.

Last year, Riskin, along with Michael Laposata, director of clinical laboratories at Massachusetts General Hospital in Boston, started a company, MedPacks, to develop portable diagnostic tests and medications that patients could use at home – before getting to the emergency room – if they thought they were having heart attacks. Such early treatment could lower the risk of death or complications by as much as 50 percent. “If we’re going to do anything innovative,” says Laposata, “we’re going to need more Dans.”

Longer profiles:

Daniel Riskin

Jia Chen

Narashima Chari

Alphabetical:

A-B

C

D-H

I-M

P-Z

TR35 Judges

2 comments. Share your thoughts »

Tagged: Communications

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me
×

A Place of Inspiration

Understand the technologies that are changing business and driving the new global economy.

September 23-25, 2014
Register »